TSX-002

DRUG2 trials

Sponsors

TesoRx Pharma, LLC

Conditions

Hypogonadism

Phase 2

Oral Testosterone for the Treatment of Hypogonadism

CompletedNCT01717768

TesoRx Pharma, LLCHypogonadism

Start: 2012-10-31End: 2014-12-31Updated: 2015-12-15

Oral Testosterone for the Treatment of Hypogonadism in Males

CompletedNCT02222558

TesoRx Pharma, LLCHypogonadism

Start: 2014-09-30End: 2015-05-31Updated: 2016-05-30

Related Papers

PD37-02 PHASE 2 RESULTS OF NOVEL ORAL TESTOSTERONE REPLACEMENT THERAPY (TSX-002) IN SYMPTOMATIC HYPOGONAGAL MEN

The Journal of Urology2015-03-31